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Boucheron,* and Martin C. Dyroff*
An impressive array of evidence has been obtained during the past decade establishing correlations
between specific DNA adducts and carcinogenesis. Many ofthe studies utilized organ specific differences
in carcinogenesis to establish the correlations. More recently, we have investigated similar relationships
between target and nontarget cell populations within the liver. Chronic exposure to methylating hepa-
tocarcinogens predominantly induces hemangiosarcomas, whereas exposure to ethylating agents causes
hepatocellular carcinomas. This cell specificity in carcinogenesis correlates well with the presence of
promutagenic DNA adducts. In the case ofmethylating agents, the nonparenchymal cells accumulate o6-
methylguanine whereas the hepatocytes do not. Exposure to ethylating agents leads to accumulation of
O'-ethyldeoxythymidine, but not 06-ethyldeoxyguanosine in hepatocytes. These differences reflect the
ability of the two cell populations to repair 06-alkylguanine and the extent of purine and pyrimidine
alkylation with methylating and ethylating agents. Hepatocytes ofrats exposed to diethylnitrosamine for
28 days have four to five times more promutagenic DNA adducts (06-alkyldeoxyguanosine and 04-alkyl-
deoxythymidine) than hepatocytes of rats exposed to nearly equimolar doses ofdimethylhydrazine. Both
06-methylguanine and 04-methyldeoxythymidine are rapidly repaired by rat hepatocytes, while only o6-
ethyldeoxyguanosine is rapidly repaired. Studies comparing the relationship between the induction of -y-
glutamyl transpeptidase-positive foci, hepatocellular carcinoma and promutagenic lesions such as 04-
ethyldeoxythymidine will be useful in understanding associations between the molecular dosimetry of
DNA adducts, initiation, and progression of hepatocarcinogenesis.
During the past decade, relationships between chem-
ical carcinogenesis and DNA adducts have been inves-
tigated for many classes of carcingens. Most attention
has focused on simple alkylating agents. Since many
alkylating agents are tissue- or even cell-specific for
cancer induction, comparisons between DNA adduct
formation and repair in target and nontarget sites can
be made. Data suggest that no single adduct is respon-
sible for the initiation ofchemical carcinogenesis. Rather,
we propose that a balance between the formation and
repair ofall promutagenic DNA adducts and the extent
of cell replication for each population of cells exposed
determines the probability of neoplasia.
Correlations between DNA Adducts
and Carcinogenesis in the Target
Organ
While the N-7 position ofguanine is known to be the
mostfrequent site ofalkylation, no correlation has been
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found between 7-alkylguanine and tumor induction (1).
In 1974, Goth and Rajewsky (2) and shortly thereafter
Kleihues and Margison (3) demonstrated that 06-alkyl-
guanine persists in rat brain, but not in liver or kidney,
following exposure to ethyl ormethylnitrosourea (MNU).
Since these agents are potent neurocarcinogens, these
data were heralded as strong evidence that 06-alkyl-
guanine was the DNA adduct responsible for brain tu-
mor induction. Further support for this was provided
by studies showing accumulation and persistence ofO6-
methylguanine (06-MG) inbrains ofrats exposed to MNU
(15). Eventhoughmethylmethanesulfonate (MMS) was
much less potent than MNU in inducing brain tumors,
tumor induction was proportionate to the amount ofO6-
MGinbrain (6). Morerecentinvestigations haveshown,
however, that persistence of 06-MG does not always
result inthe induction ofbraintumors. Gerbil, hamster,
and mouse brains develop concentrations of06-MG sim-
ilar to rats, yet have little or no susceptibility to brain
tumor induction by MNU (7). Thus, mechanisms re-
sponsible for species differences in susceptibility to brain
tumor induction by alkylating agents remain unknown.
Cell replication is an important factor in modulating
the target site and incidence of tumor formation. For
example, eventhough 06-MGispresentinmuchgreaterSWENBERG ET AL.
concentrations in livers than in colons of rats exposed
to 20 mg/kg dimethylhydrazine (SDMH), tumors occur
in the colon, not in liver following weekly exposures. A
major difference between these tissues is the extent of
cell replication, being much greater in the colon. Thus,
the amount of 06-MG per replicating cell was found to
be greater in the target organ, the colon (8,9). Similar
findings have been demonstrated in the replicating liv-
ers of newborn versus the minimally replicating livers
ofadult rats exposed to a single dose of dimethylnitro-
samine (DMN), where tumors only occurred following
exposure ofthe newborn (10). Recent studies by Dyroff
et al. (12) demonstrated dramatic differences in the in-
duction of hepatocellular carcinomas when 4-week-old
versus 8-week-old F-344 rats were exposed to 40 ppm
diethylnitrosamine (DEN) in their drinking water. The
younger animals developed a 100% incidence of hepa-
tocellular carcinomas after 6 weeks ofexposure to DEN
followed by 14 weeks additional exposure to phenobar-
bital, whereas none of the 8-week-old rats developed
carcinomas when exposed to a similar regimen. Nearly
a 10-fold greater number of -y-glutamyl transpeptidase-
positive (GGT+) foci developed in livers of4-week-old
versus 8- or 12-week-old rats exposed to 40 ppm DEN
for 4 weeks. This marked age effect may be due to the
massive difference in percent body weight gain during
DEN exposure, a crude index ofcell proliferation. The
4-week-old rats underwent a 400% increase in body
weight, compared to a 20% increase in the 8-week-old
animals. As will be discussed in greater detail later,
livers from both 4- and 8-week-old rats develop similar
concentrations of 04-ethyldeoxythymidine (= 1/105
deoxythymidine). Thus, cell replication is probably a
major factorinfluencing the induction ofGGT+ foci and
hepatocellular carcinoma in animals with similar con-
centrations of promutagenic DNA adducts.
Correlations between DNA Adducts
and Carcinogenesis in the Target
Cell
In addition to being organ specific in the induction of
neoplasms, several alkylating agents are also selective
for particular cell populations within that tissue. We
have used this phenomenon to more critically evaluate
the correlation between DNA adducts and carcinogen-
esis in the liver, where correlations between hepato-
carcinogenesis and 06-alkylguanine were poor (10,11).
Since whole liver is predominantly composed of hepa-
tocytes, these correlations might be expected iftumors
arosefromcelltypes otherthanhepatocytes. The chem-
icals involved in our investigations included two pro-
carcinogens (SDMH and DMN) that primarily induce
angiosarcomas of the liver and one (DEN) that is se-
lectiveforhepatocellularcarcinomainduction. Ourstud-
ies utilized dosing regimens similar to those employed
in chronic bioassays, since it is the molecular dosimetry
ofchronic exposure that mustbe correlated withtumors
induced by such regimens. In order to accomplish this,
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FIGURE 1. Normalized concentrations of (A) 7-MG and (B) 06-MG
(13); and (C) 06-MGMT activity (19) in rat hepatocytes (---) and
NPC ( ) during exposure to SDMH (30 ppm) in the drinking
water for up to 28 days. Data are expressed as means + SEM for
three to six rats. 06-MGMT activity is expressed as fmole of o6-
MG removed per 30 min per 106 cells.
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FIGURE 2. The initiation index for SDMH exposure of rats repre-
sents the probability of mutation due to 06-MG. Data points rep-
resent the product of 06-MG concentrations and de novo DNA
synthesis permg DNA x the amount ofDNA percellpopulation
for (-) NPC and (---) hepatocytes (21).
DNAadductswerequantitatedbyusingsensitivemeth-
ods not requiring the administration ofradioactive car-
cinogen. Studies on 7-alkylguanine and 06-methylguanine
utilized HPLC separation coupled to fluorescence de-
tection (13-16), while those on 06-ethyldeoxyguanosine
and04-alkylthymidine usedradioimmunoassays (17,18).
Following collagenase perfusion, livers were separated
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FIGURE 3. The product of (A) 06-MG concentration, (B) de novo
DNA synthesis, and amount of DNA at risk per cell population
have been used to calculate the initiation indices (C) for hepato-
cytes and NPCs of C3H mice during continuous DMN exposure
(14).
into nonparenchymal cells (NPC), consisting ofendoth-
elial and Kupffer cells, and hepatocytes by either cen-
trifugal elutriation (13,16) or low-speed centrifugation
(14,17,18).
Exposure of F-344 rats to drinking water containing
30 ppm SDMH resulted in similar concentrations of 7-
methylguanine (7-MG) in both NPC and hepatocytes
(Fig. 1) (13). Steady-state concentrations of 1000
pmole/mg DNA were attained as early as the third day
of exposure. Both cell populations had similar 06-MG
concentrations after onedayofexposure; however, from
that time on the 06-MG concentration in heptocytes de-
creased. By the third day of exposure, heptocyte 06-
MG concentrations were
- 4 pmole/mg DNA and by 16
days ofadministration concentrations had decreased to
- 1 pmole/mg DNA. After 16 to 28 days SDMH ex-
posure the 0 /N-7 ratio was
- 0.001. In contrast, the
NPC accumulated 06-MG forthe first8 days, increasing
from - 30 pmole/mg DNA on day 1 to - 57 pmole/mg
DNA on day 8. 06-MG then began to decline, reaching
a steady state of
- 20 pmole/mg DNA between 16 and
28 days exposure. The 06/N-7 ratio ofNPC was - 0.05
at this time.
The marked difference in 06-MG concentrations be-
tween NPC and hepatocytes was due to differences be-
tween the two cell populations in both the constitutive
amount and the inducibility ofthe DNA repair enzyme,
06-methylguanine DNA methyltransferase (06-MGMT).
Controlhepatocytes were showntohave
- 5timesmore
06-MGMT per cellthan NPC (19). Furthermore, the 06_
MGMT activity in hepatocytes was induced during ex-
posure to SDMH. This induction correlated with the
rapid decrease in 06-MG concentrations in hepatocytes.
Incontrast, the 06-MGMTactivityinNPCwasdepleted
during the initial 3-4 days of SDMH exposure, after
which it returned to constitutive levels. Accordingly,
the rapid accumulation of06-MG in NPC corresponded
with the depletion of 06-MGMT, while the subsequent
decline in 06-MGMT corresponded with the return of
06-MG to constitutive levels.
Parallel investigations on de novo DNA synthesis
demonstrated that the NPC underwent a marked mi-
togenic stimulus during SDMH exposure (20). Hepa-
tocytes also showed increased cellreplication; however,
the extent was much less. If one examines the product
ofcell replication x the concentration of06-MG during
SDMH exposure and normalizes this with the amount
of DNA per cell population, the area under each curve
represents the theoretical probability of initiation per
liver due to 06-MG (Fig. 2)(21). Using this calculation,
the probability of inducing angiosarcomas is 17-fold
greater than that of hepatocellular carcinomas. Fur-
thermore, the predicted probability of hepatocellular
carcinoma induction is highest in the first 4 days of
SDMH exposure. Abioassayusingthe samedosingreg-
imen demonstrated thatangiosarcomas were induced in
93% of the rats, while hepatocellular carcinomas were
produced in 40% of the animals (13). Thus, this model
forinitiation underestimated the latter, suggestingthat
DNA adducts other than 06-MG might be involved. As
willbediscussed ingreaterdetailinsubsequentportions
ofthisreview, itislikelythat04-methyldeoxythymidine
also contributes to the initiation ofhepatocytes (18).
Studies also have been conducted on C3H mice ex-
posed to DMN (14). The NPC progressively accumu-
lated 06-MG over 32 days ofexposure to 10 ppm DMN,
reaching
- 50 pmole/mg DNA (Fig. 3). In contrast, the
hepatocytes maintained constant amounts of06-MG (-
5 pmole/mg DNA) throughout the exposure regimen.
Both cell populations exhibited a 2- to 3-fold increase in
de novo DNA synthesis during the 32-day period of
exposure to DMN. When these data were used to pre-
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FIGURE 4. Hepatic GGT+ foci induction versus weeks ofexposure
to 40 ppm DEN in 8-week-old rats (12).
dict the likelihood ofinitiation due to 06-MG, the target
cells (NPC) were predicted to be 2.5 times more likely
to be initiated during the 32-day exposure than the he-
patocytes, a finding in general agreement with several
bioassays.
Similar methods were used to investigate the mech-
anisms of hepatocellular carcinoma induction by DEN.
Initial studies using fluorescence detection for 06-ethyl-
guanine (06-EG) were hampered by concentrations of
06-EG too low to be detected by this method (22). Since
06-EG is known to be repaired in a manner similar to
06-MG, it was postulated that most initiation due to O6-
EG would occur during the first 1 to 2 weeks of expo-
sure. Therefore, if hepatocellular carcinoma induction
by DEN was primarily due to 06-EG, initiation also
should occur primarily during the first 2 weeks of ex-
posure. This was tested by exposing rats to 40 ppm
DEN in their drinking water for up to 10 weeks, fol-
lowed by placing the animals on the Solt-Farber selec-
tion regimen for GGT+ foci (12). The data in Figure 4
clearly demonstrate that initiation was not confined to
the first 2 weeks. Rather, the number of GGT+ foci
remained similar to controls during the first 2 weeks
and then progressively increased withincreasinglength
of exposure. These data strongly suggested that DNA
adducts other than 06-EG were responsible for hepa-
tocellular carcinoma induction.
In collaboration with Manfred Rajewsky, we exam-
ined the molecular dosimetry of 06-ethyldeoxyguano-
sine (06-EtdGuo) and 04-ethylthymidine (04-EtdThd)
during continuous exposure to DEN for up to 11 weeks
(Fig. 5) (17). Using monoclonal antibodies in sensitive
radioimmunoassays, we showed that 04-EtdThd accu-
mulated in hepatocyte DNA to concentrations more than
50times greaterthan 06-EtdGuo, inspiteofits chemical
formation in the DNA at only 1/3 to 1/4 the amount of
06-EtdGuo. Thus, the minor DNA adduct, 04-EtdThd,
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FIGURE 5. Concentrations of (e) 04-EtdThd and (0) 06-EtdGuo in
DNA ofhepatocytes ofrats exposed to 40 ppm DEN in the drink-
ing water for 2 days to 11 weeks. Data are expressed as means
± SEM exceptpointsmarked byanasterisk (*), whereallsamples
were below the limit of detection (</200 fmole) (17).
wasclearly amajorpromutagenic adductin hepatocytes
of rats continually exposed to DEN. After 2 days of
DEN exposure, the NPC contained similar amounts of
06-EtdGuo and 04-EtdThd, being 1/3 that of the cor-
responding hepatocyte 04-EtdThd concentrations. At
49 and 77 days of exposure, the 04-EtdThd concentra-
tion in NPC remained about 1/2 that ofthe hepatocytes;
however, the NPC 06-EtdGuo concentrations were 1/4
and 1/20 that of the 04-EtdThd, respectively.
Subsequent studies utilized polyclonal antibodies to
04-EtdThd to demonstrate that similar steady-state
concentrations (- 1 per 105 dThd) were achieved when
4-week-old F-344 rats were exposed to 40 ppm DEN
(Fig. 6) (12). These animals were much more sensitive
to the induction of GGT+ foci and hepatocellular car-
cinoma. Sincethemoleculardosimetry of4- and 8-week-
old rats was similar, this increased susceptibility most
likely reflects increased cell proliferation associated with
the rapid growth of these younger animals (12).
As shown in Figure 6, GGT+ foci appeared earlier
and in greater number in 4-week-old rats, than in 8-
week-old rats (Fig. 4)(12). Of greater interest was the
demonstration that the number of foci per cubic centi-
meter plateaued. Since foci are believed to represent
initiation of hepatocytes, which is a cumulative event,
this was unexpected. The most likely interpretation of
these datais that the plateau represents a steady state,
during which initiated cells are being formed at a rate
similar to that oftheir loss. Loss could be the result of
a change in phenotype or cell death at the single cell
stage of focus development.
Polyclonal antibodies to 04-methylthymidine (04-
MedThd) were alsodeveloped, permittingthefirst mea-
surements of this minor alkylation product in animals
exposed to methylating agents (18). Following a single
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20 mg/kg exposure to SDMH, 04-MedThd was present
in rat liver at 1/100 the amount of 06-MG. 04-MedThd
was removed from rat liver relatively rapidly, having
a half-time of
- 20 hr (Fig. 7). In contrast, 04-EtdThd
had a half-time of - 11 days, whether it was formed by
a single exposure to 15 mg/kg DEN or by continuous
exposure to 40 ppm DEN in the drinking water for 4
weeks. No evidence for an inducible repair system for
04-EtdThd was demonstrable. Thus, differences in re-
pair rates of 04-MedThd and 04-EtdThd provides a
mechanism to explain the greater ability of ethylating
versus methylating agents to induce hepatocellular car-
cinoma in the rat. This is shown in Table 1, where al-
kylation data from hepatocyte DNA ofrats exposed to
equimolar doses of SDMH and DEN for up to 28 days
were compared (18). The data presented are accumu-
lations of 06-alkylguanine, 04-alkylthymidine, and the
sum ofthese two promutagenic DNA adducts at various
times of exposure and therefore represent the net ef-
fects of formation and repair. Under these conditions,
06-MG attained steady-state concentrations
- 10 times
higher than 06-EG, while 04-MedThd plateaued at con-
centrations 10 times lower than 04-EtdThd. Since nearly
equal amounts of04-alkylthymidine were formed chem-
ically, it is apparent that the difference in the rate of
repairis the predominant factor leading to higherlevels
of 04-EtdThd versus 04-MedThd. In contrast, differ-
ences in formation are the principal factors leading to
higher levels of06-MG vs. 06-EG. It is also ofinterest
to note that even though 04-MedThd is formed at only
1/100 the amount of O-MG, it accumulates to nearly
equal concentrations in hepatocyte DNA ofrats contin-
uously exposed to SDMH. These data clearly show that
themoleculardosimetry ofDNAadducts resultingfrom
single dose studies are a poor surrogate for data from
chronic exposure regimens. One must match bioassay
data with molecular dosimetry data derived from com-
parable dosing regimens.
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FIGURE 6. Correlation of i)0u-EtdThd persistence with (1) hepatic
GGT + foci and (0) tumor induction in 8-week-old rats (12).
Potential of Molecular Dosimetry in
Risk Assessment
The field ofrisk assessment is rapidly changing from
presentingqualitative riskassessments tomakingquan-
titative estimates of risk. Numerous mathematical
models have been developed, ranging from linear ex-
trapolation based on a one-hit one-cancer theory, to
present day multistage and multihit models thought to
better approximate the steps involved in carcinogen-
esis. A critical problem is that the accuracy of these
models can not be validated with bioassay data. Data
from the ED,, study, which involved exposure of
24,192 mice to 2-acetylaminofluorene, have been used
but are woefully inadequate for low-dose extrapolation,
since the dose range employed covered less than one
order of magnitude (23). This study points out the fu-
tility of conducting animal bioassays to validate true
low dose extrapolations (four to six orders of magni-
tude), since millions of animals would be required to
detect a response at such extremely low doses. An al-
ternative methodusingmoleculardosimetryasthemea-
sure of exposure followed by an examination of tumor
incidence relative to DNA adducts has been suggested.
Present-day models for quantitative risk assessment use
measures ofexternal exposure such as ppm in air, water,
or diet. Such measures of exposure cannot account for
nonlinearities in the dose response (24,25). The sche-
matic shown in Figure 8 shows some of the possible
fates ofexternal exposure. Absorption ofachemical can
range from 0 to 100%, yielding the internal exposure or
dose. This internal dose can be metabolized to an acti-
vated or a detoxified form, again ranging from 0 to
100%, yielding the internal activated dose. This dose is
distributed to critical and noncritical sites. By meas-
uringthe dose at target sites, one should have the most
10.0-
N1.0
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FIGURE 7. Persistence of04-EtdThd and 04-MedThd following pulse
(o) DEN or (A) SDMH or (0) continuous DEN administration. The
curve for 04-EtdThd following continuous DEN has been shifted
12 hr to correspond with 12 hr time points in pulse dosing regi-
mens. All control liver values were below the limits ofdetection.
Data are expressed as means ± SEM for three to six rats (18).
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Table 1. Concentrations of 06-alkylguanine and 04-alkyldeoxythymidine in hepatocyte DNA
of rats exposed to 40 ppm DEN or 30 ppm SDMH in drinking H20.ab
Total concentration of
Exposure period, Concentration of Concentration of 04-alkyl dT + 06-alkyl G
days Carcinogen 06-alkyl G, pmole/,umole G 04-alkyl dT, pmole/,Lmole dT pmole/,mole DNAC
8 DEN 0.3 5.0 2.0
SDMH 6.3 0.8 1.6
16 DEN 0.25 8.5 2.4
SDMH 1.6 0.8 0.6
28 DEN <0.2 10.0 2.8
SDMH 1.6 1.0 0.6
aData of Richardson et al. (18).
bThe exposures result in - 29 ,umole DEN and 34 ,umole SDMH per kg per day.
'Since dT/dG ratios ranged from 1.28 to 1.35, 1 ,umole DNA contains 0.22 ,umole dG and 0.28 ,umole dT. The sums expressed are therefore
adjusted accordingly.
External kl Internal k2 Biotransformation k3 -Detoxification
Exposure OExposure
k4
Biologically Effective Dose
Biological
Endpoints
FIGURE 8. Relationship between external exposure and biologically
effective dose.
accurate data for determining the true dose response
relationship. DNA adducts represent a critical target
site dose that can be utilized for such studies. As the
dose-response relationship isestablished, moleculardo-
simetry may extend the observable range of biological
data. Evenwhenitbecomesimpracticalto obtain tumor
data due to the large numbers of animals needed, the
relationships between external exposure and target site
dosimetry can be determined. Furthermore, this rela-
tionship can be compared across species, including ex-
posed humans. The inclusion of such data could place
quantitative risk assessment on a much firmer scientific
base than is presently available. Scientists conducting
studies on DNA adducts are therefore encouraged to
provide their counterparts in risk assessment with data
suitable for developing models based on molecular
dosimetry.
Portions ofthis research were funded by grant no. 20023-01 to Duke
University from the National Institutes of Health.
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